Podcast
Novartis’ Win-Win Approach to Greener Drug Development
“Environmental Sustainability can be a substantial differentiator for CDMOs” Jürgen Wieland, Development Environmental Sustainability Lead at Novartis, is engaged to integrate sustainability into development processes, including reducing the emissions of clinical trials. Jürgen brings over 20 years of finance and
3 November 2020